Presentation is loading. Please wait.

Presentation is loading. Please wait.

Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma  Stephen.

Similar presentations


Presentation on theme: "Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma  Stephen."— Presentation transcript:

1 Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma  Stephen D. Smith, Shruti Gandhy, Ajay K. Gopal, Prathima Reddy, Mazyar Shadman, Brian G. Till, Ryan C. Lynch, Sandra Kanan, Andrew Cowan, Lauren Low, Brian T. Hill  Clinical Lymphoma, Myeloma and Leukemia  Volume 19, Issue 1, Pages (January 2019) DOI: /j.clml Copyright © 2018 Elsevier Inc. Terms and Conditions

2 Figure 1 PFS and OS Among All 37 Patients
Abbreviations: OS = Overall survival; PFS = progression-free survival. Clinical Lymphoma, Myeloma and Leukemia  , 48-52DOI: ( /j.clml ) Copyright © 2018 Elsevier Inc. Terms and Conditions

3 Figure 2 PFS by High-Risk Mipi-C Versus Other
Abbreviations: MIPI = Mantle Cell Lymphoma International Prognostic Index; PFS = progression-free survival. Clinical Lymphoma, Myeloma and Leukemia  , 48-52DOI: ( /j.clml ) Copyright © 2018 Elsevier Inc. Terms and Conditions


Download ppt "Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma  Stephen."

Similar presentations


Ads by Google